相关实验视频

Updated: Jun 12, 2025

Preparation and Evaluation of 99mTc-labeled Tridentate Chelates for Pre-targeting Using Bioorthogonal Chemistry

Preparation and Evaluation of 99mTc-labeled Tridentate Chelates for Pre-targeting Using Bioorthogonal Chemistry

Published on: February 4, 2017

合成和评估99m标有Tc标签的D含Pro-Gly的标记剂,针对PSMA

Zuojie Li¹, Yuhao Jiang^1,2, Qing Ruan^1,2

¹Key Laboratory of Radiopharmaceuticals of the Ministry of Education, College of Chemistry, NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Beijing Normal University, Beijing 100875, P. R. China.

Molecular pharmaceutics

|September 19, 2024

概括

一种新的标记着技术-99m (99mTc) 的标记物,[99mTc]Tc-EUKPG-EDDA,显示脏对前列腺特异性膜抗原 (PSMA) 成像的吸收减少. 这种追踪器在前列腺癌诊断中提供了改进的瘤可视化.

科学领域:

核医学是一种核医学.
放射化学放射化学是指辐射化学.
在瘤学瘤学.

背景情况:

前列腺特异性膜抗原 (PSMA) 是前列腺癌诊断和治疗的关键目标.
现有的99mTc标记的PSMA标记剂经常患有高脏吸收,限制了临床效用.
开发具有改善药理动力学特征的新型标记剂至关重要.

研究的目的:

为了合成和评估新的99mTc标记的PSMA向标记剂.
为了解决当前PSMA成像剂的高吸收问题.
为了识别具有优越性质的标记物,用于前列腺癌瘤成像.

主要方法:

通过DPro-Gly链接器合成一种新型连接体 (EUKPG).
准备和评估了三个99mTc标记的复合物:[99mTc]Tc-EUKPG-EDDA,[99mTc]Tc-EUKPG-TPPTS,以及[99mTc]Tc-EUKPG-TPPMS.
评估药物动力学特性,包括脏吸收,清除和瘤与背景的比率.
在体外和体内有关PSMA特异性的研究.

主要成果:

[99mTc]Tc-EUKPG-EDDA表现出良好的药理动力学,其吸收显著减少 (14.04 ± 0.23% ID/g).
这种标记物表现出快速清除和低非目标器官吸收,导致高瘤与背景比率 (瘤/血液:7.47,瘤/肌肉:12.65).
对PSMA的高特异性在体外和体内均得到证实.

结论:

[99mTc]Tc-EUKPG-EDDA为PSMA向瘤成像提供了一个有前途的分子追踪器.
其改善的药理动力学特征,特别是减少脏积累,增强了其在前列腺癌中临床应用的潜力.
与现有药物相比,这种追踪剂可以更好地可视化瘤.

关键词:

99mTcc 的时间.在PSMA上,PSMA可以在PSMA上进行交易.斯佩克特 (Spectre) 是一个运动场.一个追踪器追踪器.瘤是一个瘤.

更多相关视频

Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression

Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression

Published on: February 3, 2023

Synthesis of 68Ga Core-doped Iron Oxide Nanoparticles for Dual Positron Emission Tomography /T1Magnetic Resonance Imaging

Synthesis of 68Ga Core-doped Iron Oxide Nanoparticles for Dual Positron Emission Tomography /T1Magnetic Resonance Imaging

Published on: November 20, 2018

相关概念视频

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET

Positron Emission Tomography

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...